US Edition
UBS Group Cuts ALX Oncology (NASDAQ:ALXO) Price Target to $1.00
Summary by watchlistnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
UBS Group Cuts ALX Oncology (NASDAQ:ALXO) Price Target to $1.00
ALX Oncology (NASDAQ:ALXO – Free Report) had its price target trimmed by UBS Group from $1.20 to $1.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a buy rating on the stock. Several other analysts have also commented on the stock. Piper Sandler lifted their price target on shares […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage